| Kelli Rae Lund, MD | |
|
904 Washington Ave Ste 210, Holland, MI 49423-7724 | |
| (616) 748-2850 | |
| Not Available |
| Full Name | Kelli Rae Lund |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 904 Washington Ave Ste 210, Holland, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689629693 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 4301065859 (Michigan) | Primary |
| Entity Name | Holland Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780888099 PECOS PAC ID: 0446157291 Enrollment ID: O20031218000484 |
News Archive
Humans and mice have previously unknown and potentially critical differences in one of the genes responsible for Duchenne muscular dystrophy (DMD). Researchers writing in the open access journal BMC Biology have found that two major features of a key DMD gene are present in most mammals, including humans, but are specifically absent in mice and rats, calling into question the use of the mouse as the principal model animal for studying DMD.
The aim of personalizing cancer treatments by targeting genomic mutations in the cancer has seen rapid advances in recent years. However, many of these targeted cancer therapies have been more frequently identified for adult patients. Recognizing a need to further explore genomic profiling in pediatric malignancies, the Hugs for Brady Foundation has committed $300,000 to the precision medicine initiative at Rutgers Cancer Institute of New Jersey.
Now, a new study published on the preprint server medRxiv aims to analyze the immune response over time, using multi-omics in the study of a single cell.
Researchers at McMaster University have discovered a solution to a long-standing medical mystery in Huntington's disease (HD). HD is a brain disease that can affect 1 in about 7,000 people in mid-life, causing an increasing loss of brain cells at the centre of the brain.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., announced that the U.S. Food and Drug Administration (FDA) approved EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the treatment of hypertension to lower blood pressure in adults.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kelli Rae Lund, MD 904 Washington Ave Ste 210, Holland, MI 49423-7724 Ph: () - | Kelli Rae Lund, MD 904 Washington Ave Ste 210, Holland, MI 49423-7724 Ph: (616) 748-2850 |
News Archive
Humans and mice have previously unknown and potentially critical differences in one of the genes responsible for Duchenne muscular dystrophy (DMD). Researchers writing in the open access journal BMC Biology have found that two major features of a key DMD gene are present in most mammals, including humans, but are specifically absent in mice and rats, calling into question the use of the mouse as the principal model animal for studying DMD.
The aim of personalizing cancer treatments by targeting genomic mutations in the cancer has seen rapid advances in recent years. However, many of these targeted cancer therapies have been more frequently identified for adult patients. Recognizing a need to further explore genomic profiling in pediatric malignancies, the Hugs for Brady Foundation has committed $300,000 to the precision medicine initiative at Rutgers Cancer Institute of New Jersey.
Now, a new study published on the preprint server medRxiv aims to analyze the immune response over time, using multi-omics in the study of a single cell.
Researchers at McMaster University have discovered a solution to a long-standing medical mystery in Huntington's disease (HD). HD is a brain disease that can affect 1 in about 7,000 people in mid-life, causing an increasing loss of brain cells at the centre of the brain.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., announced that the U.S. Food and Drug Administration (FDA) approved EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the treatment of hypertension to lower blood pressure in adults.
› Verified 7 days ago
Ling Wang, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 602 Michigan Ave, Holland, MI 49423 Phone: 616-392-5141 | |
Daniel Golin, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3235 N Wellness Dr, #120a, Holland, MI 49424 Phone: 616-399-0902 | |
Ronald Garett Shook, DO Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 926 Washington Ave, Bldg C, Holland, MI 49423 Phone: 616-393-0166 | |
Nancy Macdonald, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 588 E Lakewood Blvd, Holland, MI 49424 Phone: 616-494-5850 Fax: 616-494-5901 | |
Dr. Allison Lynn Rund, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 588 E Lakewood Blvd, Holland, MI 49424 Phone: 616-494-5840 Fax: 616-494-5901 | |
Dr. Diane Devoll Vandermeer, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 926 Washington Ave, Holland, MI 49423 Phone: 616-393-0166 Fax: 616-393-0167 | |
Karen Locke, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 588 E Lakewood Blvd Fl 1, Holland, MI 49424 Phone: 616-494-5840 |